DJIA 18,010.68 -115.44 -0.64%
NASDAQ 5,070.03 -27.95 -0.55%
S&P 500 2,107.39 -13.40 -0.63%
market minute promo

Antares Pharma, Inc. (NASDAQ: ATRS)

2.12 -0.06 (-2.75%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

ATRS $2.12 -2.75%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $2.19
Previous Close $2.18
Daily Range $2.11 - $2.24
52-Week Range $1.82 - $3.20
Market Cap $279.3M
P/E Ratio -8.72
Dividend (Yield) $0.00 (0.0%)
Volume 2,638,117
Average Daily Volume 899,014
Current FY EPS -$0.12

Sector

Healthcare

Industry

Healthcare IT

Antares Pharma, Inc. (ATRS) Description

The Company develops, produces and markets pharmaceutical delivery products, including transdermal gels, oral fast melting tablets and reusable needle-free and disposable mini-needle injector systems. Website: http://www.antarespharma.com/

News & Commentary

Why Shares in Antares Pharma, Inc. Burst Today

Antares Pharma, Inc. shares tumbled after it priced its secondary stock offering.

Top Analyst Upgrades and Downgrades: Antares, Michael Kors, Palo Alto, Ralph Lauren, Chipotle, Erics

Top Analyst Upgrades and Downgrades: Antares, Michael Kors, Palo Alto, Ralph Lauren, Chipotle, Ericsson, and More

Health Care Sector Update for 05/28/2015: KPTI, ATRS, ZFGN

Benzinga's Top Initiations

Piper Jaffray Initiates Antares Pharma With Overweight

Antares Pharma's (ATRS) CEO Eamonn Hobbs on Q1 2015 Results - Earnings Call Transcript

How To Manage The Risks To Investing In The Aging Population

Health Care Sector Update for 03/31/2015: DGX, BGMD, ATRS

US Stock Futures Slide Ahead Of Economic Data

Antares Pharma Announces FDA Approval of TEV-TROPIN 10 mg Needle-Free Injector

See More ATRS News...

ATRS's Top Competitors

ATRS $2.12 (-2.75%)
Current stock: ATRS
$0.00 (0.00%)
Current stock:
MDT $76.32 (-1.15%)
Current stock: MDT
COV $0.00 (0.00%)
Current stock: COV